Yuan Chen

1.6k total citations
66 papers, 1.1k citations indexed

About

Yuan Chen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yuan Chen has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Yuan Chen's work include Advanced Breast Cancer Therapies (8 papers), Ferroptosis and cancer prognosis (5 papers) and Prostate Cancer Treatment and Research (5 papers). Yuan Chen is often cited by papers focused on Advanced Breast Cancer Therapies (8 papers), Ferroptosis and cancer prognosis (5 papers) and Prostate Cancer Treatment and Research (5 papers). Yuan Chen collaborates with scholars based in China, United States and Taiwan. Yuan Chen's co-authors include Chih‐Ho Lai, Ho Lin, Jer‐Tsong Hsieh, U‐Ging Lo, Chun‐Jung Lin, Casey M. Rebholz, Josef Coresh, Andreea M. Rawlings, Michelle M. Estrella and Dalin He and has published in prestigious journals such as Nature, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Yuan Chen

63 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yuan Chen 395 251 163 131 131 66 1.1k
Xiuhua Wang 357 0.9× 243 1.0× 165 1.0× 141 1.1× 93 0.7× 56 1.2k
Tomohiro Matsuo 352 0.9× 227 0.9× 161 1.0× 230 1.8× 158 1.2× 130 1.2k
Rongrong Li 333 0.8× 93 0.4× 120 0.7× 107 0.8× 228 1.7× 76 1.0k
Iwona Bil‐Lula 279 0.7× 108 0.4× 125 0.8× 139 1.1× 103 0.8× 73 919
Jian‐Ri Li 575 1.5× 306 1.2× 177 1.1× 299 2.3× 243 1.9× 141 1.6k
Min Tan 350 0.9× 144 0.6× 139 0.9× 80 0.6× 113 0.9× 57 856
Kojiro Ohba 474 1.2× 218 0.9× 216 1.3× 242 1.8× 259 2.0× 116 1.2k
Yuan Ruan 798 2.0× 409 1.6× 284 1.7× 141 1.1× 146 1.1× 92 1.6k

Countries citing papers authored by Yuan Chen

Since Specialization
Citations

This map shows the geographic impact of Yuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Chen more than expected).

Fields of papers citing papers by Yuan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Chen. The network helps show where Yuan Chen may publish in the future.

Co-authorship network of co-authors of Yuan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Chen. A scholar is included among the top collaborators of Yuan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Chen. Yuan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Amir, Eitan, Mark E. Robson, Nour Abuhadra, et al.. (2024). The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review. Critical Reviews in Oncology/Hematology. 202. 104455–104455.
3.
Anjos, Carlos Henrique dos, Pedram Razavi, Anton Safonov, et al.. (2024). Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer. npj Breast Cancer. 10(1). 92–92. 4 indexed citations
4.
Chen, Yuan, U‐Ging Lo, Rey-Chen Pong, et al.. (2024). SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade. Cell Death and Disease. 15(9). 678–678. 8 indexed citations
5.
Liang, Jialong, et al.. (2024). Successful bilateral lung transplantation in a five-year-old child with pulmonary interstitial fibrosis caused by an ABCA3 gene mutation. Transplant Immunology. 85. 102056–102056. 1 indexed citations
6.
Ferraro, Emanuela, Anton Safonov, Yuan Chen, et al.. (2023). Abstract P4-02-01: Efficacy of HER2 ADCs against HER2 inhibitor resistance alterations in the PI3K and MAPK pathways in HER2-positive breast cancer. Cancer Research. 83(5_Supplement). P4–2. 2 indexed citations
7.
Li, Chenyi, Ling‐Yu Wang, Yuan Chen, et al.. (2023). Clostridium scindens metabolites trigger prostate cancer progression through androgen receptor signaling. Journal of Microbiology Immunology and Infection. 56(2). 246–256. 17 indexed citations
8.
Peng, Ping, Yujie Zhang, Shuchang Zhou, et al.. (2023). EGFR-TKIs plus stereotactic body radiation therapy (SBRT) for stage IV Non-small cell lung cancer (NSCLC): A prospective, multicenter, randomized, controlled phase II study. Radiotherapy and Oncology. 184. 109681–109681. 27 indexed citations
9.
Xu, W., et al.. (2023). A novel antidiuretic hormone governs tumour-induced renal dysfunction. Nature. 624(7991). 425–432. 24 indexed citations
10.
Tang, Xiaowei, Bei Luo, Shu Huang, et al.. (2023). FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma. European journal of medical research. 28(1). 419–419. 5 indexed citations
11.
Guan, Bing, Ning Zhou, Cheng‐Yang Wu, et al.. (2021). Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer. International Journal of Molecular Sciences. 22(23). 13085–13085. 11 indexed citations
12.
Nie, Xiaowei, Chenyou Shen, Jianxin Tan, et al.. (2020). Periostin. Circulation Research. 127(9). 1138–1152. 47 indexed citations
13.
Kuo, Chia‐Jung, Hui-Yu Wu, Mei-Zi Huang, et al.. (2019). Helicobacter pylori Induces IL-33 Production and Recruits ST-2 to Lipid Rafts to Exacerbate Inflammation. Cells. 8(10). 1290–1290. 19 indexed citations
14.
Chen, Yuan, et al.. (2018). Anti-Inflammatory Effect of Geniposide on Osteoarthritis by Suppressing the Activation of p38 MAPK Signaling Pathway. BioMed Research International. 2018. 1–11. 44 indexed citations
15.
Chen, Yuan, David T.W. Tzeng, Yi‐Ping Huang, et al.. (2018). Antrocin Sensitizes Prostate Cancer Cells to Radiotherapy through Inhibiting PI3K/AKT and MAPK Signaling Pathways. Cancers. 11(1). 34–34. 45 indexed citations
16.
Lin, Hwai‐Jeng, Chia‐Der Lin, Yuan Chen, et al.. (2017). Cytolethal Distending Toxin Enhances Radiosensitivity in Prostate Cancer Cells by Regulating Autophagy. Frontiers in Cellular and Infection Microbiology. 7. 223–223. 18 indexed citations
17.
Chen, Yuan, Chun‐Jung Lin, Hwai‐Jeng Lin, et al.. (2016). Molecular Mechanisms and Potential Clinical Applications of Campylobacter jejuni Cytolethal Distending Toxin. Frontiers in Cellular and Infection Microbiology. 6. 9–9. 36 indexed citations
18.
Wang, Tao, Wen Song, Yuan Chen, et al.. (2015). Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling. Clinical Cancer Research. 22(6). 1531–1544. 21 indexed citations
19.
He, Dalin, Lei Li, Guodong Zhu, et al.. (2014). ASC-J9 Suppresses Renal Cell Carcinoma Progression by Targeting an Androgen Receptor–Dependent HIF2α/VEGF Signaling Pathway. Cancer Research. 74(16). 4420–4430. 81 indexed citations
20.
Lv, Jing, Zhimin Zhao, Yuan Chen, et al.. (2012). The Chinese Herbal Decoction Danggui Buxue Tang Inhibits Angiogenesis in a Rat Model of Liver Fibrosis. Evidence-based Complementary and Alternative Medicine. 2012. 1–11. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026